The program of gene expression in a cell is controlled by a selected array of transcription factors that are activated in response to extracellular cues. The focus of this section is on the discovery and functional analysis of the network of genes involved in the development of myelin-forming glial cells. Previous experiments in cloning and characterizing individual transcription factors (e.g. MYT1, MYT1-L, rKr2) and components of the signal transduction pathways (e.g. PTPepsilon) expressed by oligodendrocytes have expanded to a more global effort. Employing microarray technology, we have identified sets of transcription factors and cell surface receptors that are expressed by oligodendrocytes at distinct stages in their development. Members from two families of molecules that mediate cell-cell interactions, the ephrin and neuropilin receptors, were found to be selectively and highly expressed by oligodendrocytes. Ongoing functional studies suggest a possible role for these molecules in the migration of oligodendrocyte progenitors and in the establishment of neuronal-glial contacts. Our CNP-geo transgenic mice, in which oligodendrocytes are specifically tagged with a lacZ-antibiotic resistance reporter, have been used as transplantation donors to determine whether bone marrow stem cell populations are capable of migrating into the nervous system and differentiating into myelin-forming glial cells and whether the geo-tagged cells can promote recovery when introduced into jimpymsd mice that lack mature oligodendrocytes. These studies form the basis for devising strategies to promote remyelination in diseases such as multiple sclerosis, Pelizaeus-Merzbacher disease and spinal cord injury, either by directly supplying normal progenitors or by stimulating endogenous oligodendrocyte progenitors to proliferate, migrate and differentiate.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Intramural Research (Z01)
Project #
1Z01NS002528-19
Application #
6432887
Study Section
(LDN)
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
2000
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Hudson, Lynn D; Romm, Elena; Berndt, Jo Ann et al. (2011) A tool for examining the role of the zinc finger myelin transcription factor 1 (Myt1) in neural development: Myt1 knock-in mice. Transgenic Res 20:951-61
Szuchet, Sara; Nielsen, Joseph A; Lovas, Gabor et al. (2011) The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype. Eur J Neurosci 34:1906-22
Nielsen, Joseph A; Lau, Pierre; Maric, Dragan et al. (2009) Integrating microRNA and mRNA expression profiles of neuronal progenitors to identify regulatory networks underlying the onset of cortical neurogenesis. BMC Neurosci 10:98
Lau, Pierre; Verrier, Jonathan D; Nielsen, Joseph A et al. (2008) Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci 28:11720-30
Nielsen, Joseph A; Maric, Dragan; Lau, Pierre et al. (2006) Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J Neurosci 26:9881-91
Kim, Hyunsook; Barton, Elisabeth; Muja, Naser et al. (2005) Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology 146:1772-9
Romm, Elena; Nielsen, Joseph A; Kim, Jin G et al. (2005) Myt1 family recruits histone deacetylase to regulate neural transcription. J Neurochem 93:1444-53
Muja, Naser; Lovas, Gabor; Romm, Elena et al. (2004) Expression of a catalytically inactive transmembrane protein tyrosine phosphatase epsilon (tm-PTP epsilon) delays optic nerve myelination. Glia 48:278-97
Nielsen, Joseph A; Berndt, Jo Ann; Hudson, Lynn D et al. (2004) Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells. Mol Cell Neurosci 25:111-23
Hudson, Lynn D (2003) Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene. J Child Neurol 18:616-24

Showing the most recent 10 out of 22 publications